The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Sahoo, S. K., Panyam, J., Prabha, S., & Labhasetwar, V. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00127-x · Cited by 990
Torchilin, V. P. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00166-4 · Cited by 680
Hjelm, H., Hjelm, K., & Sjöquist, J. (1972) · FEBS Letters · doi:10.1016/0014-5793(72)80680-x · Cited by 612
Design of Folic Acid‐Conjugated Nanoparticles for Drug Targeting
Stella, B., Arpicco, S., Peracchia, M. T., Desmaële, D., Hoebeke, J., Renoir, M., D'Angelo, J., Cattel, L., & Couvreur, P. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200011)89:11<1452::aid-jps8>3.0.co;2-p · Cited by 553
Characterization of nanoparticle uptake by endothelial cells
Davda, J., & Labhasetwar, V. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00923-1 · Cited by 524
Recent advances in tumor-targeting anticancer drug conjugates
Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.084 · Cited by 490
Panyam, J., & Labhasetwar, V. (2003) · Pharmaceutical Research · doi:10.1023/a:1022219003551 · Cited by 466
Ligand-targeted liposomal anticancer drugs
Sapra, P., & Allen, T. M. (2003) · Progress in Lipid Research · doi:10.1016/s0163-7827(03)00032-8 · Cited by 438
Nanosystems in Drug Targeting: Opportunities and Challenges
Vasir, J. K., Reddy, M. K., & Labhasetwar, V. D. (2005) · Current Nanoscience · doi:10.2174/1573413052953110 · Cited by 414
Current methods for attaching targeting ligands to liposomes and nanoparticles
Nobs, L., Buchegger, F., Gurny, R., & Allémann, E. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20098 · Cited by 379
Targeted drug conjugates: principles and progress
Garnett, M. C. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00227-7 · Cited by 262
Park, J. S., Han, T. H., Lee, K. Y., Han, S. S., Hwang, J. J., Moon, D. H., Kim, S. Y., & Cho, Y. W. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.07.011 · Cited by 250
Selective targeting of antibody-conjugated nanoparticles to leukemic cells and primary T-lymphocytes
Dinauer, N., Balthasar, S., Weber, C., Kreuter, J., Langer, K., & von Briesen, H. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.02.038 · Cited by 234
Trastuzumab-modified nanoparticles: Optimisation of preparation and uptake in cancer cells
Steinhauser, I., Spänkuch, B., Strebhardt, K., & Langer, K. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.05.016 · Cited by 216
Drug-conjugated monoclonal antibodies for the treatment of cancer
LAMBERT, J. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.04.017 · Cited by 210
Fahmy, T. M., Fong, P. M., Goyal, A., & Saltzman, W. M. (2005) · Materials Today · doi:10.1016/s1369-7021(05)71033-6 · Cited by 192
Protein A from Staphylococcus aureus
Sjöholm, I. (1975) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1975.tb03906.x · Cited by 147
Monoclonal antibody drug immunoconjugates for targeted treatment of cancer
Trail, P. A., King, D. H., & Dubowchik, G. M. (2003) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-002-0352-9 · Cited by 140
Cirstoiu-Hapca, A., Bossy-Nobs, L., Buchegger, F., Gurny, R., & Delié, F. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.12.002 · Cited by 116
Protein Delivery: Physical Systems
Sanders, L. M., & Hendren, R. W. (2010) · Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) · doi:10.1007/b112382 · Cited by 103
Juillerat‐Jeanneret, L., & Schmitt, F. (2006) · Medicinal Research Reviews · doi:10.1002/med.20086 · Cited by 90
Monoclonal antibody drug conjugates in the treatment of cancer
Trail, P. A., & Bianchi, A. B. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00012-6 · Cited by 88
Leu, D., Manthey, B., Kreuter, J., Speiser, P. P., & Delucax, P. P. (1984) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600731028 · Cited by 88
Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours
Cegnar, M., Kristl, J., & Kos, J. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.12.1557 · Cited by 73
Self-citationCegnar, M., Premzl, A., Zavašnik‐Bergant, V., Kristl, J., & Kos, J. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.07.021 · Cited by 72
Self-citationCegnar, M., Kos, J., & Kristl, J. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.04.003 · Cited by 70
Self-citationIllum, L., Jones, P. D. E., Kreuter, J., Baldwin, R. W., & Davis, S. S. (1983) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(83)90019-4 · Cited by 55
Lynch, I. (2007) · Physica A: Statistical Mechanics and its Applications · doi:10.1016/j.physa.2006.06.008 · Cited by 50
Monoclonal antibodies and therapy of human cancers
Funaro, A., Horenstein, A. L., Santoro, P., Cinti, C., Gregorini, A., & Malavasi, F. (2000) · Biotechnology Advances · doi:10.1016/s0734-9750(00)00043-4 · Cited by 41
Degradable Controlled Release Systems Useful for Protein Delivery
Roskos, K. V., & Maskiewicz, R. (2002) · Pharmaceutical biotechnology · doi:10.1007/0-306-46803-4_2 · Cited by 10
Rowland, R. E. S., Taylor, P. W., & Florence, A. T. (2005) · Journal of Drug Delivery Science and Technology · doi:10.1016/s1773-2247(05)50055-8 · Cited by 7
Beketić-Orešković, L., Šarčević, B., Malenica, B., & Novak, D. (1993) · PubMed · Cited by 7
Cited by
Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,824
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Parveen, S., Misra, R., & Sahoo, S. K. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.016 · Cited by 1,436
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Current advances in research and clinical applications of PLGA-based nanotechnology
Lü, J.-M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., & Chen, C. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.15 · Cited by 903
Polylactic acid: Synthesis and biomedical applications
Singhvi, M. S., Zinjarde, S. S., & Gokhale, D. V. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14290 · Cited by 883
Metadata
- Authors
- Kocbek, P., Obermajer, N., Cegnar, M., Kos, J., & Kristl, J.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2007-07
- Volume
- 120
- Issue
- 1-2
- Pages
- 18-26
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2042973822
- Cited by
- 436
- References
- 34
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.